Patents by Inventor Varda Shalev
Varda Shalev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12020783Abstract: A method of evaluating lung cancer risk by generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a lung cancer risk of said target individual by classifying said set of features using said at least one classifier. Each of said plurality of historical and current blood test results comprises results of one or more selected blood tests such as white blood cells blood test results, biochemistry test results, platelets blood test results including at least one of platelets count and mean platelet volume (MPV) and/or a combination of smoking history and red cell test results.Type: GrantFiled: June 7, 2021Date of Patent: June 25, 2024Assignee: Medial Research Ltd.Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein
-
Patent number: 11651189Abstract: A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.Type: GrantFiled: October 20, 2019Date of Patent: May 16, 2023Assignee: Medial Research Ltd.Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein
-
Publication number: 20210295960Abstract: A method of evaluating lung cancer risk by generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a lung cancer risk of said target individual by classifying said set of features using said at least one classifier. Each of said plurality of historical and current blood test results comprises results of one or more selected blood tests such as white blood cells blood test results, biochemistry test results, platelets blood test results including at least one of platelets count and mean platelet volume (MPV) and/or a combination of smoking history and red cell test results.Type: ApplicationFiled: June 7, 2021Publication date: September 23, 2021Applicant: Medial Research Ltd.Inventors: Nir KALKSTEIN, Yaron KINAR, Varda SHALEV, Gabriel CHODICK, Inbal GOLDSHTEIN
-
Patent number: 11031105Abstract: A method of evaluating lung cancer risk by generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a lung cancer risk of said target individual by classifying said set of features using said at least one classifier. Each of said plurality of historical and current blood test results comprises results of one or more selected blood tests such as white blood cells blood test results, biochemistry test results, platelets blood test results including at least one of platelets count and mean platelet volume (MPV) and/or a combination of smoking history and red cell test results.Type: GrantFiled: November 5, 2014Date of Patent: June 8, 2021Assignee: Medial Research Ltd.Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein
-
Publication number: 20200050917Abstract: A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.Type: ApplicationFiled: October 20, 2019Publication date: February 13, 2020Applicant: Medial Research Ltd.Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein
-
Patent number: 10452970Abstract: A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.Type: GrantFiled: October 20, 2016Date of Patent: October 22, 2019Assignee: Medial Research Ltd.Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein
-
Publication number: 20170039334Abstract: A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.Type: ApplicationFiled: October 20, 2016Publication date: February 9, 2017Applicant: Medial Research Ltd.Inventors: Nir KALKSTEIN, Yaron KINAR, Varda SHALEV, Gabriel CHODICK, Inbal GOLDSHTEIN
-
Patent number: 9474490Abstract: A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.Type: GrantFiled: May 2, 2013Date of Patent: October 25, 2016Assignee: Medial Research Ltd.Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein
-
Publication number: 20160292379Abstract: A method of evaluating lung cancer risk by generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a lung cancer risk of said target individual by classifying said set of features using said at least one classifier. Each of said plurality of historical and current blood test results comprises results of one or more selected blood tests such as white blood cells blood test results, biochemistry test results, platelets blood test results including at least one of platelets count and mean platelet volume (MPV) and/or a combination of smoking history and red cell test results.Type: ApplicationFiled: November 5, 2014Publication date: October 6, 2016Inventors: Nir KALKSTEIN, Yaron KINAR, Varda SHALEV, Gabriel CHODICK, Inbal GOLDSHTEIN
-
Publication number: 20140235956Abstract: A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.Type: ApplicationFiled: May 2, 2013Publication date: August 21, 2014Inventors: Nir Kalkstein, Yaron Kinar, Varda Shalev, Gabriel Chodick, Inbal Goldshtein